(Q34288541)

1 August 2017

1 reference

title

Variation in protection by BCG: implications of and for heterologous immunity (English)

1 reference

1 August 2017

P E Fine

1

1 reference

PubMed ID

7475776

1 August 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

1 August 2017

1 reference

1 August 2017

346

1 reference

1 August 2017

1339-1345

1 reference

1 August 2017

8986

1 reference

Modern vaccines. Mycobacterial diseases

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Efficacy and applicability of mass B. C.G. vaccination in tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Identification of an effective vaccine against tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Effectiveness of BCG vaccination in England and Wales in 1983.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Contributions of northern populations to the understanding of tuberculin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Evaluation of BCG vaccination among Puerto Rican children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Species level identification of non-tuberculous mycobacteria from South Indian BCG trial area during 1981

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

The effect of oral Mycobacterium vaccae on subsequent responses of mice to BCG sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Neisseria lactamica and Neisseria meningitidis share lipooligosaccharide epitopes but lack common capsular and class 1, 2, and 3 protein epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Is protection against shigellosis induced by natural infection with Plesiomonas shigelloides?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Field experiment with BCG vaccine in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Protective effect of BCG vaccination in Norway 1956-73

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Childhood tuberculosis in Sweden. An epidemiological study made six years after the cessation of general BCG vaccination of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

BCG vaccination of Indian infants in Saskatchewan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

The effectiveness of bacillus Calmette-Guérin (BCG) vaccination against tuberculosis. A case-control study in Treaty Indians, Alberta, Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Protective effect of BCG vaccination in infant Asians: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

B.C.G. vaccination in Birmingham: An assessment of its contribution to tuberculosis control in 1956–1967

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

A contact study to evaluate the BCG vaccination programme in Seoul

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Evaluation of the effectiveness of BCG vaccination using the case-control method in Buenos Aires, Argentina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Case-control study on evaluation of BCG vaccination of newborn in Rangoon, Burma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Protective value of BCG vaccination in children in Bangkok, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

1 reference

7 January 2021

The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

A case-control study of BCG and childhood tuberculosis in Cali, Colombia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

Evaluation of the protective effect of BCG vaccination by a case-control study in Yaounde, Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992348-9

7 January 2021

10.1016/S0140-6736(95)92348-9

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

7475776